Inflammatory Bowel Disease

Top Story

FDA accepts investigational NDA for ulcerative colitis therapy

FDA accepts investigational NDA for ulcerative colitis therapy
January 21, 2020
Meeting News

Crohn’s & Colitis Congress: Collaboration between physicians, patients ‘critical’

January 21, 2020
AUSTIN, Texas — Healio Gastroenterology and Liver Disease will be on-site at the Austin Convention Center starting Thursday as a media partner for the…
In the Journals

Microscopic colitis may increase risk for incident IBD

January 20, 2020
Patients with microscopic colitis were at increased risk for incident inflammatory bowel disease, according to study results. Hamed Khalili, MD, of the…
In the Journals

Remicade is top among biologic-naive patients with UC

January 16, 2020
Remicade ranked highest for induction of remission and endoscopic improvement among biologic-naive patients, according to a meta-analysis of treatments for moderately to…
More Headlines »